![]() The global Dental Bone Grafts And Substitutes Market size is expected to reach USD 1.42 billion by 2030, registering a CAGR of 9.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing number of dental implant surgeries, the growing target population, technological advancement in synthetic bone grafts, and new product launches are the major growth propelling factors for the market. According to the Population Reference Bureau 2018 statistics, by 2050, from 13 countries to around 82 countries across the world are anticipated to have more than 20% of the geriatric population (65 years and above). Thus, perpetual growth in the population aged 60 years and above is anticipated to result in an increased prevalence of periodontal diseases. These aforementioned factors are driving the market. Moreover, the rising adoption of synthetic bone grafts over autografts and allografts due to advantages such as lesser chances of disease transmission, and better acceptance is further propelling the market. Moreover, growing medical tourism in developing countries, as well as a growing number of periodontists and oral surgeons, are some other factors propelling growth. Countries such as South Korea, India, and Turkey are constantly gaining popularity in dental tourism due to cheaper costs and advanced treatment options. The onset of the pandemic significantly affected the sales of dental bone graft products as almost all the dental services were halted for a major part of 2020. However, as control measures and vaccines were effectively introduced globally, essential dental treatments and sales of dental products rose to assist in a significant recovery. Many key players in the market have reported high growth for their dental implants and biomaterial products in 2021. Related Press Release@ Dental Bone Grafts And Substitutes Market Report Dental Bone Grafts And Substitutes Market Highlights
0 Comments
![]() The global Inhalation Anesthesia Market size is expected to reach USD 2.4 billion by 2030 and is expected to expand at a CAGR of 9.0% in the forecast period, from 2022 to 2030, according to a new report by Grand View Research, Inc. Inhalation anesthetics offer shorter induction period and recovery time along with better efficacy and lesser adverse effects as compared to other alternatives, thus providing better anesthetic effect during surgical procedures. They also provide excellent control over the duration of anesthesia in the patient. Thus, inhalation anesthesia is being preferred over intravenous anesthesia due to these advantages. Drugs administered through inhalation anesthesia have a quick onset of action even at low dose as compared to intravenous anesthesia. Using inhalation route for administration helps avoid excessive dosage and keeps the patient’s autonomic functions intact. As these drugs are eliminated via lungs, they have lower chances of accumulation in the body. Hence, they result in lower risk of hepatotoxicity. In addition, drugs administered through inhalation route have limited tolerance and addiction level as compared to other alternatives routes. With the launch of innovative respiratory products such as AnaConDa (Anaesthetic Conserving Device), administration of inhalation general anesthetic agents such as sevoflurane, isoflurane, & other agents have become easier. Inhalation anesthesia is considered to be the best alternative for patients who are on ventilation for more than 24 hours as it becomes easy to monitor the patient’s health. Major concern associated with anesthetic gas is that only 5% account for patient use and the rest 95% is released in the atmosphere, which leads to greenhouse effect of these gases. The comparative analysis of sevoflurane, isoflurane, and desflurane based on atmospheric time span and global atmospheric concentrations indicates that desflurane poses a high potential threat for environment. Related Press Release@ Inhalation Anesthesia Market Report Inhalation Anesthesia Market Report Highlights
![]() The global Softgel Capsules Market size is estimated to reach USD 13.09 billion by 2030 registering a CAGR of 7.9%, according to a new report by Grand View Research, Inc. Softgel capsules are proven to be the choice of formulation for poorly soluble drugs and enhance the absorption time of most drug molecules. Its advantages over tablets and other oral formulations have led to the increased adoption of softgel capsules across the globe. Ease of swallowing, taste masking, improved bioavailability, non-reactive, aesthetically appealing, and longer shelf life are the factors influencing its wide acceptance. Leading players like Catalent, Eurocaps, and many others, are developing vegan capsules to broaden their vegan consumer base as the softgel capsule segment registers nearly 40% of their overall revenue. Large Pharma companies like Pfizer, Novartis, Bayer, and Procter and Gamble, collaborate with leading Contract Manufacturing Organizations (CMO) to provide cost-effective products in the highly competitive market. Research to develop an oral vaccine to treat respiratory infection caused by the SaRS-CoV-2 virus has fueled the R&D of softgel manufacturers. Additionally, the shift towards a healthier lifestyle and immunity-boosting vitamins, have also surged the softgel market post the outbreak of the COVID-19 pandemic. Related Press Release@ Softgel Capsules Market Report Softgel Capsules Market Report Highlights
List of Key Players in Softgel Capsules Market
The global Kyphoplasty Market size is expected to reach USD 950.83 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.2% from 2022 to 2030. The increasing geriatric population is a key contributing factor attributable to the market growth during the forecast period. Compression fractures affect many individuals worldwide. Vertebral compression fractures (VCFs) are the most common fracture in osteoporosis patients, affecting approximately 750,000 people every year. The occurrence of this condition gradually rises as people age, with an estimated 40% of women aged 80 and older affected.
During the outbreak of COVID-19, non-emergency procedures have significantly impacted the Kyphoplasty market. As restrictions resulted in delays to a number of procedures. Most nations have elevated restrictions on elective surgery. In April 2020, the North American Spine Society (NASS) released a guidance document comprehensive of clinical considerations and recommendations for surgeries and procedures within the following classes: emergent, urgent, and elective. As a result, it is estimated to drive market growth after the recommencement of surgical procedures at full force. The COVID-19 pandemic has significantly affected the surgical and clinical practice of spine surgeons across the globe. As per an Asia Pacific Spine Society (APSS) Survey, the COVID-19 pandemic had changed spine surgeons’ clinical practices. The study intended to examine the impact of the pandemic on the clinical practices of spine surgeons within the Asia Pacific region. A total of 222 respondents from 19 nations completed the questionnaire. The study resulted in the mean reduction of clinic volume for all nations was 48.1%. Thus, there was a substantial decrease in the number of surgeries performed in Malaysia, Japan, India, the Philippines, and South Korea. Kyphoplasty can offer faster pain relief and enhanced functional outcomes compared with conservative treatment. Multiple myeloma, one of the cancer form weaken the bones of the back, which leads to fractures and kyphosis. While continuous sitting and bad posture can be the reason for the development of kyphosis. It develops because sitting puts substantial pressure on the vertebrae, wearing them down. Increasing demand for minimally invasive surgical procedures, improving health reimbursement, technological advancement in new products, and increasing incidence of osteoporosis are other factors expected to promote the market growth during the forecast period. For instance, in September 2020, Stryker’s SpineJack implantable fracture reduction system received the U.S. Centers for Medicare & Medicaid Services (CMS) new technology add-on payment as part of the 2021 inpatient prospective payment system. Related Press Release@ Kyphoplasty Market Report Kyphoplasty Market Report Highlights
![]() The Europe Digital Health Market size is expected to reach USD 323.4 billion by 2030 and is expected to expand at a CAGR of 27.1% over the forecast period, according to a new report by Grand View Research, Inc. Increasing aging population, rise in prevalence of chronic disorders in Europe, and growing demand for remote patient monitoring are among the major factors driving the market growth in this region. In addition, improved IT infrastructure, growing digitalization of healthcare, and rising medical expenses are also anticipated to accelerate the market growth over the forecast period. Moreover, the shortage of healthcare professionals and overburdened healthcare facilities are also expected to increase the adoption of digital health platforms. The mHealth technology segment held the dominant revenue share of 34.4% in 2021, owing to growing internet and smartphone penetration in Europe and increasing adoption of mHealth platforms by medical professionals for better patient engagement. In addition, the rise in government initiatives for the promotion and development of mHealth platforms also supports the high growth of the segment. For instance, in 2017, the mHealth hub program was initiated with the financial support of WHO-ITU and co-funded by the European Commission in Europe, to support different regions and countries in setting up large-scale programs for the integration of mHealth in the healthcare systems. By component, the services segment dominated the market in 2021 with a revenue share of 63.7%, owing to the growing preference for healthcare platform upgrade services for better patient engagements in remote locations. In addition, training, staffing, maintenance, and resource allocation for pre and post-installation of digital platforms to provide better remote healthcare services also support the high growth of the segment. However, the software segment is anticipated to register the highest growth rate during forecast years owing to the rapid adoption of healthcare applications and increase in the development of improved technical advanced software for health management. The demand for digital health platforms has increased due to the emergence of the COVID-19 pandemic. The fear of coronavirus infection decreased the in-person health consultation and increased the demand for virtual healthcare services which in turn favor the growth of the market over the forecast years. In addition, increasing demand for mobile health platforms among the medical professionals and the patients due to the lockdown and shutdown impact and staff shortage concerns during the COVID-19 pandemic also driving the market growth in 2020 and forecast years. The COVID-19 pandemic also creates immense opportunities for the market players to develop improved digital health platforms due to the surge in demand for mHealth applications, healthcare IT systems, virtual care, wearables, and telehealth, which in turn anticipated to fuel the market growth in this period. Related Press Release@ Europe Digital Health Market Report Europe Digital Health Market Report Highlights
Cancer Diagnostics Market - Future Trends, Revenue Growth & Leading Players, Forecast To 20268/10/2022 The global Cancer Diagnostics Market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression.
Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear. Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests. Related Press Release@ https://www.grandviewresearch.com/press-release/global-cancer-diagnostics-market Further key findings from the report suggest:
|
Archives
October 2023
|